Skip to main content

Table 3 Therapy and outcome

From: Prognosis of pathogen-proven acute respiratory distress syndrome diagnosed from a protocol that includes bronchoalveolar lavage: a retrospective observational study

 

All patients (N = 70)

Pathogen-proven ARDS group (N = 50)

Pathogen-unproven ARDS group (N = 20)

p

Therapy

 Neuromuscular blocking agents

12 (17)

8 (16)

4 (20)

0.732

 Corticosteroid therapy

29 (41)

20 (40)

9 (45)

0.791

 Prone position

5 (7)

3 (6)

2 (10)

0.619

 Hemodialysis

21 (30)

15 (30)

6 (30)

1.000

 VA ECMO

5 (7)

4 (8)

1 (5)

1.000

 VV ECMO

12 (17)

11 (22)

1 (5)

0.158

 Tracheostomy

28 (40)

20 (40)

8 (40)

1.000

 Appropriate antibiotic therapy for causative pathogens within day 3

48 (96)

Outcome

 Ventilator-free days of 28 days

16 (0–20)

18 (7–20)

4 (0–22)

0.112

 ICU-free days of 28 days

13 (0–16)

13 (5–16)

1 (0–15)

0.034

 ICU mortality

15 (21)

5 (10)

10 (50)

0.0006

 Hospital-free days of 28 days

0 (0–6)

0 (0–6)

0 (0–7)

0.613

 Hospital mortality

20 (29)

9 (18)

11 (55)

0.0038

  1. Values are given as the median (interquartile range) or number (%). p values were calculated using Fisher’s exact test or the Mann-Whitney U test
  2. ARDS acute respiratory distress syndrome, VA ECMO veno-arterial extracorporeal membrane oxygenation, VV veno-venous, ICU intensive care unit